IBDEI0PA ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12395,0)
 ;;=284.2^^70^756^15
 ;;^UTILITY(U,$J,358.3,12395,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12395,1,1,0)
 ;;=1^284.2
 ;;^UTILITY(U,$J,358.3,12395,1,8,0)
 ;;=8^Myelophthisic Anemia
 ;;^UTILITY(U,$J,358.3,12395,2)
 ;;=^334037
 ;;^UTILITY(U,$J,358.3,12396,0)
 ;;=281.9^^70^756^8
 ;;^UTILITY(U,$J,358.3,12396,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12396,1,1,0)
 ;;=1^281.9
 ;;^UTILITY(U,$J,358.3,12396,1,8,0)
 ;;=8^Deficiency Anemia
 ;;^UTILITY(U,$J,358.3,12396,2)
 ;;=^123801
 ;;^UTILITY(U,$J,358.3,12397,0)
 ;;=284.89^^70^756^5
 ;;^UTILITY(U,$J,358.3,12397,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12397,1,1,0)
 ;;=1^284.89
 ;;^UTILITY(U,$J,358.3,12397,1,8,0)
 ;;=8^Anemia d/t CA or Drugs
 ;;^UTILITY(U,$J,358.3,12397,2)
 ;;=^87880
 ;;^UTILITY(U,$J,358.3,12398,0)
 ;;=281.1^^70^756^7
 ;;^UTILITY(U,$J,358.3,12398,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12398,1,1,0)
 ;;=1^281.1
 ;;^UTILITY(U,$J,358.3,12398,1,8,0)
 ;;=8^B12 Defic Anemia NEC
 ;;^UTILITY(U,$J,358.3,12398,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,12399,0)
 ;;=281.2^^70^756^9
 ;;^UTILITY(U,$J,358.3,12399,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12399,1,1,0)
 ;;=1^281.2
 ;;^UTILITY(U,$J,358.3,12399,1,8,0)
 ;;=8^Folate-Def Anemia
 ;;^UTILITY(U,$J,358.3,12399,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,12400,0)
 ;;=282.60^^70^756^18
 ;;^UTILITY(U,$J,358.3,12400,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12400,1,1,0)
 ;;=1^282.60
 ;;^UTILITY(U,$J,358.3,12400,1,8,0)
 ;;=8^Sickle Cell Anemia NOS
 ;;^UTILITY(U,$J,358.3,12400,2)
 ;;=^330077
 ;;^UTILITY(U,$J,358.3,12401,0)
 ;;=285.0^^70^756^19
 ;;^UTILITY(U,$J,358.3,12401,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12401,1,1,0)
 ;;=1^285.0
 ;;^UTILITY(U,$J,358.3,12401,1,8,0)
 ;;=8^Sideroblastic Anemia
 ;;^UTILITY(U,$J,358.3,12401,2)
 ;;=^7204
 ;;^UTILITY(U,$J,358.3,12402,0)
 ;;=286.9^^70^757^2
 ;;^UTILITY(U,$J,358.3,12402,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12402,1,1,0)
 ;;=1^286.9
 ;;^UTILITY(U,$J,358.3,12402,1,8,0)
 ;;=8^Defective Coagulation,Unspec
 ;;^UTILITY(U,$J,358.3,12402,2)
 ;;=^87267
 ;;^UTILITY(U,$J,358.3,12403,0)
 ;;=446.6^^70^757^9
 ;;^UTILITY(U,$J,358.3,12403,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12403,1,1,0)
 ;;=1^446.6
 ;;^UTILITY(U,$J,358.3,12403,1,8,0)
 ;;=8^Thrombotic Thrombocytopenic Purpura (TTP)
 ;;^UTILITY(U,$J,358.3,12403,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,12404,0)
 ;;=451.9^^70^757^8
 ;;^UTILITY(U,$J,358.3,12404,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12404,1,1,0)
 ;;=1^451.9
 ;;^UTILITY(U,$J,358.3,12404,1,8,0)
 ;;=8^Thrombophlebitis
 ;;^UTILITY(U,$J,358.3,12404,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,12405,0)
 ;;=287.5^^70^757^6
 ;;^UTILITY(U,$J,358.3,12405,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12405,1,1,0)
 ;;=1^287.5
 ;;^UTILITY(U,$J,358.3,12405,1,8,0)
 ;;=8^Thrombocytopenia Nos
 ;;^UTILITY(U,$J,358.3,12405,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,12406,0)
 ;;=287.1^^70^757^5
 ;;^UTILITY(U,$J,358.3,12406,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12406,1,1,0)
 ;;=1^287.1
 ;;^UTILITY(U,$J,358.3,12406,1,8,0)
 ;;=8^Qualitative Platelet Defects
 ;;^UTILITY(U,$J,358.3,12406,2)
 ;;=^101922
 ;;^UTILITY(U,$J,358.3,12407,0)
 ;;=287.30^^70^757^4
 ;;^UTILITY(U,$J,358.3,12407,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12407,1,1,0)
 ;;=1^287.30
 ;;^UTILITY(U,$J,358.3,12407,1,8,0)
 ;;=8^Primary Thrombocytopenia (ITP)
 ;;^UTILITY(U,$J,358.3,12407,2)
 ;;=^332841
 ;;^UTILITY(U,$J,358.3,12408,0)
 ;;=238.71^^70^757^7
 ;;^UTILITY(U,$J,358.3,12408,1,0)
 ;;=^358.31IA^8^2
 ;;^UTILITY(U,$J,358.3,12408,1,1,0)
 ;;=1^238.71
 ;;^UTILITY(U,$J,358.3,12408,1,8,0)
 ;;=8^Thrombocytosis,Essential
